In 2024, the U.S. Drug Enforcement Administration (DEA) indicated they intend to reclassify marijuana for a Schedule III drug. This rescheduling will identify that cannabis has genuine clinical purposes and can help open up the door to analysis on other likely cure employs. Sublingual Administration THC can even be consumed https://thcdisposables.co.uk/